Stay updated on ED-SCLC Immuno-Therapy Clinical Trial
Sign up to get notified when there's something new on the ED-SCLC Immuno-Therapy Clinical Trial page.

Latest updates to the ED-SCLC Immuno-Therapy Clinical Trial page
- Check3 days agoChange DetectedThe page loses certain background topic labels and the MedlinePlus Genetics link, reducing some background resources while keeping the study details and structure intact.SummaryDifference0.1%

- Check10 days agoChange DetectedThe page now displays Revision: v3.5.4, replacing the previous Revision: v3.5.3, indicating a new version of the page content.SummaryDifference0.0%

- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedAn updated study site listing appears as Taoyuan, Taiwan, 333, and the Taoyuan District listing is removed; the page also adds Lung cancer as a topic and includes related topics such as MedlinePlus Genetics.SummaryDifference0.1%

- Check31 days agoChange DetectedThe page footer now shows an updated system/version label (“Revision: v3.5.3”). Related topic text in the surrounding MedlinePlus/links area was adjusted, without changing the study’s core details.SummaryDifference0.1%

- Check38 days agoChange DetectedOno Pharmaceutical Co., Ltd. was added as a collaborator; revision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check46 days agoChange DetectedAdded related topics such as Lung cancer and MedlinePlus Genetics to the page.SummaryDifference0.1%

Stay in the know with updates to ED-SCLC Immuno-Therapy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ED-SCLC Immuno-Therapy Clinical Trial page.